Benzinga | Feb 2, 2021 06:31AM EST

Bio-Techne Q2 Adj. EPS $1.62 Beats $1.37 Estimate, Sales $224.30M Beat $206.50M Estimate

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $1.62 per share which beat the analyst consensus estimate of $1.37 by 18.25 percent. This is a 50 percent increase over earnings of $1.08 per share from the same period last year. The company reported quarterly sales of $224.30 million which beat the analyst consensus estimate of $206.50 million by 8.62 percent. This is a 21.29 percent increase over sales of $184.93 million the same period last year.